Question:

How does new research contradict the GAO’s assertions on lab billing?

Answer:

The Braid-Forbes analysis demonstrated that in order for the GAO’s claims to be accurate, the volume of Medicare billed panel tests would decrease while the volume of individual component tests should have risen greatly. However, the research revealed that the comprehensive metabolic panel and individual component test volume decreased. The analysis offered a comparison of the first two quarters for both 2017 (before the Protecting Access to Medicare Act of 2014 [PAMA]) as well as 2018 (after PAMA), which indicated that the comprehensive metabolic panel’s Medicare volume dropped by two percent with the individual component test falling in volume by an average of five percent.

This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.

Facebook
Twitter
LinkedIn
Email
Print

CPT® copyright 2021 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.